معرفی
Tobias Allander is an Adjunct Senior Lecturer at Karolinska Institutet, affiliated with the Department of Microbiology, Tumor and Cell Biology. He also holds a position as Senior Consultant at the Department of Clinical Microbiology, Karolinska University Hospital. His research focuses on HIV genetic variation, evolution, and resistance; enterovirus evolution and spread; and pandemic preparedness, particularly for coronaviruses. He leads a research group that develops novel methods for estimating HIV infection times using next-generation sequencing (NGS) and biomarkers, supported by NIH, VR, and ALF grants. His work spans viral discovery, molecular epidemiology, and clinical virology, with a strong emphasis on respiratory and bloodborne viruses.
- University: Karolinska Institutet
- Department: Department of Microbiology, Tumor and Cell Biology
- Clinical Affiliation: Karolinska University Hospital, Clinical Microbiology
Tobias Allander's research interests include:
- Virology
- Molecular Epidemiology
- Viral Evolution
- Pandemic Preparedness
- Next-Generation Sequencing (NGS)
- Clinical Microbiology
His publications highlight expertise in viral discovery, particularly human bocavirus and polyomaviruses, and advanced NGS applications. Recent articles investigate SARS-CoV-2 variant transmission, HIV incidence estimation, and enterovirus D68 outbreaks. His group contributes to Sweden's pandemic surveillance efforts, including the SciLifeLab program, and maintains collaborations with Los Alamos National Laboratory and Stockholm University.
As an advisor, Tobias Allander supervises PhD candidates, including Amanj Bajalan. He has not received any explicitly mentioned scientific awards in the provided texts. His clinical work at Karolinska University Hospital involves diagnostic studies and virus discovery in pediatric and immunocompromised populations.
